相关实验视频

Updated: Jul 19, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

IRAK 抑制剂可以改善胰岛素耐药性小鼠的胰岛素敏感性,这些小鼠被食高脂肪饮食

Mostafa Allahyari¹, Athena Rajaie², Hossein Fallah²

¹Student Research Committee, Kerman University of Medical Sciences, Kerman7616913555, Iran.

Asian biomedicine : research, reviews and news

|August 8, 2023

概括

一种IRAK抑制剂有效地改善了小鼠的胰岛素敏感性,降低了小鼠的血糖,与pioglitazone相似. 将IRAK抑制剂与pioglitazone结合起来并没有增强这些益处.

科学领域:

代谢性疾病研究研究.
炎症和免疫学炎症和免疫学
药理干预措施药理干预

背景情况:

肥胖引起的炎症通过炎症性细胞因子和通类受体 (TLR) 信号传递促进胰岛素抵抗.
介素-1受体相关激酶 (IRAK) 在TLR信号传递中至关重要,激活NF-κB通路,从而降低胰岛素的疗效.
针对NF-κB途径的上层介质是一种策略,因为途径本身缺乏安全的抑制剂.

研究的目的:

在小鼠模型中研究IRAK抑制剂对胰岛素抵抗的影响.
为了评估IRAK抑制对高脂肪养小鼠血清生物化学因素的影响.
评估IRAK抑制与pioglitazone结合的潜在协同效应.

主要方法:

在使用12周高脂肪饮食的C57BL/6J小鼠中诱导了胰岛素抵抗.
小鼠接受IRAK 1/4抑制剂 (IRAKi),皮奥格利塔或两种药物两周.
使用HOMA-IR量化胰岛素敏感性,并测量血糖和胰岛素水平.

主要成果:

与对照组相比,IRAKi显著降低了血糖水平,提高了胰岛素敏感性.
在改善胰岛素敏感性方面,IRAKi单独治疗的疗效与皮奥格利塔相当.
当IRAKi与pioglitazone同时使用时,没有观察到协同效应.

结论:

IRAK 抑制剂代表了增加胰岛素敏感性的可行的治疗方法.
在改善胰岛素敏感性方面,IRAK抑制剂的疗效与皮奥格利塔相当.
与皮奥格利塔和IRAKi的联合治疗没有比单一治疗提供额外的好处.

关键词:

脂肪组织的脂肪组织.在糖尿病中,糖尿病是血糖类的.杂交C57BLBL是一种内杂种.这是一种炎症炎症炎症炎症.胰岛素耐药性是一种胰岛素耐药性.鼠标鼠标鼠标鼠标提亚利丁二氧化.

更多相关视频

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

相关概念视频

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...